Therapy News and Research

RSS

Largest U.S. hepatitis C trial yields treatment insights

Community-Based WIN-R Study Shows Significantly Better Outcomes with Weight-Based Dosing

24 May 2006

MRI cost-effective for some women at high-risk of breast cancer

A computer model simulation suggests that adding breast MRI screening may be cost-effective for women of certain ages who carry BRCA1 and BRCA2 gene mutations.

23 May 2006

Study identified characteristics of caregivers that may increase symptoms in dementia patients

Troublesome symptoms that accompany dementia - including wandering, hallucinations and restlessness - may increase if the patients' caregivers are young, less educated, over-burdened or depressed.

23 May 2006

Body has more than one body clock

Research conducted at Oregon Health & Science University suggests that contrary to popular belief, the body has more than one "body clock."

23 May 2006

Robotic joystick reveals how brain controls movement

By training a group of human subjects to operate a robot-controlled joystick, Johns Hopkins researchers have shown that the slower the brain "learns" to control certain muscle movements, the more likely it is to remember the lesson over the long haul.

23 May 2006

Pros and cons of starting multiple sclerosis treatment early

An editorial accompanying a published debate on the pros and cons of starting treatment early in the course of multiple sclerosis comes down in favor of early treatment for this potentially devastating disease.

23 May 2006

Childhood verbal abuse triggers adult anxiety, depression

A new study by Florida State University researchers has found that people who were verbally abused as children grow up to be self-critical adults prone to depression and anxiety.

23 May 2006

Women who pile on the kilos more at risk of breast cancers

According to a large new study women who pile on the kilos as adults increase their risk of all types of breast cancer even if they do not take hormone replacement therapy after menopause.

23 May 2006

Clinical trials funded by for-profit organizations more likely to report positive

Cardiovascular clinical trials published between 2000 and 2005 were significantly more likely to report positive findings if they were funded by for-profit organizations than those funded by not-for-profit organizations, according to a study in JAMA: The Journal of the American Medical Association.

23 May 2006

Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women

According to a new study, women who gain weight in adulthood face a higher lifetime risk of all types of breast cancer even if they do not take hormone replacement therapy after menopause.

23 May 2006

Patients more satisfied if they have more contact with pharmacist

Getting hospital-based pharmacists out from "behind the counter" to work directly with inpatients and health care teams reduces medication errors and problems, according to a University of Iowa and Department of Veterans Affairs review of previously published studies.

23 May 2006

New technique to deliver insulin genes to pancreas

Researchers at Baylor University Medical Center at Dallas and the Baylor Research Institute have developed a novel technique to deliver insulin genes to the pancreas, the organ that produces the body's insulin.

23 May 2006

Role of partial nephrectomy in the treatment of upper tract transitional cell carcinoma

Traditionally, upper tract transitional cell carcinoma (TCC) is managed with nephroureterectomy with excision of a bladder cuff.

22 May 2006

Arthritis drug wins approval for use in children with Crohn's disease

The Food and Drug Administration in the U.S. has given approval for the drug Remicade for use in children with active Crohn's disease(CD), a chronic and debilitating condition.

21 May 2006

New drug for Parkinson's gets FDA approval

The Food and Health Administration in the U.S. has granted approval for a new drug to treat patients with Parkinson's disease.

21 May 2006

New rheumatoid arthritis drugs may put patients at risk of infections and cancer

Anti-TNF (tumor necrosis factor) therapies are a tried and tested type of medication used for treating rheumatoid arthritis and the drugs provide benefit to many of thousands of patients worldwide.

21 May 2006

MRI provides an early alert for polycystic kidney disease

A new method using magnetic resonance imaging (MRI) accurately tracks structural changes that predict functional changes earlier than standard blood and urine tests in people with autosomal dominant polycystic kidney disease (PKD).

17 May 2006

Depression in multiple sclerosis patients clue to better treatment

Depression increases in some patients with multiple sclerosis over time, according to neuropsychologists, and this research finding could help reduce depression in patients and aid in better treatment strategies.

17 May 2006

FDA approves Azilect for the treatment of Parkinson's

The Food and Drug Administration today approved Azilect (rasagiline), a new molecular entity, for the treatment of Parkinson's disease.

17 May 2006

Study shows strong association between treatment with TNF-blocking antibodies and development of serious infections

A new meta-analysis of many previous studies of TNF- (tumor necrosis factor) blocking antibodies for treatment of rheumatoid arthritis has confirmed a previously discovered increased risk for serious infection and has found that cancer also is a potential risk associated with the drugs.

17 May 2006